[
    [
        {
            "time": "2018-11-05",
            "original_text": "机构评级精选：控量挺价增速换挡 五粮液评级获上调",
            "features": {
                "keywords": [
                    "五粮液",
                    "评级",
                    "上调",
                    "控量挺价"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "机构评级精选：控量挺价增速换挡 五粮液评级获上调",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-10-30",
            "original_text": "【中银医药】华兰生物2018三季报点评：血制品见底回升，四价流感疫苗开始放量",
            "features": {
                "keywords": [
                    "华兰生物",
                    "三季报",
                    "血制品",
                    "流感疫苗",
                    "放量"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【中银医药】华兰生物2018三季报点评：血制品见底回升，四价流感疫苗开始放量",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-10-31",
            "original_text": "财通证券：华兰生物买入评级",
            "features": {
                "keywords": [
                    "华兰生物",
                    "买入评级",
                    "财通证券"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "财通证券：华兰生物买入评级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-11-01",
            "original_text": "华兰生物早盘封跌停 成交额6.17亿元封单8724手",
            "features": {
                "keywords": [
                    "华兰生物",
                    "跌停",
                    "成交额",
                    "封单"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物早盘封跌停 成交额6.17亿元封单8724手",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 10,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2018-11-02",
            "original_text": "华兰生物：血制品保持稳定增长 预计疫苗业务开始盈利",
            "features": {
                "keywords": [
                    "华兰生物",
                    "血制品",
                    "稳定增长",
                    "疫苗业务",
                    "盈利"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华兰生物：血制品保持稳定增长 预计疫苗业务开始盈利",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-11-03",
            "original_text": "华兰生物:业绩延续高增长,血制品盈利能力逐步恢复",
            "features": {
                "keywords": [
                    "华兰生物",
                    "业绩",
                    "高增长",
                    "血制品",
                    "盈利能力",
                    "恢复"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华兰生物:业绩延续高增长,血制品盈利能力逐步恢复",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]